Jack Cash Per Share vs Capex To Revenue Analysis

JNH Stock

CAD 0.03 0.01 20.00%

Jack Nathan financial indicator trend analysis is infinitely more than just investigating Jack Nathan Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jack Nathan Medical is a good investment. Please check the relationship between Jack Nathan Cash Per Share and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jack Nathan Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash Per Share vs Capex To Revenue

Cash Per Share vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jack Nathan Medical Cash Per Share account and Capex To Revenue. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Jack Nathan's Cash Per Share and Capex To Revenue is -0.15. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Jack Nathan Medical, assuming nothing else is changed. The correlation between historical values of Jack Nathan's Cash Per Share and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Jack Nathan Medical are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Cash Per Share i.e., Jack Nathan's Cash Per Share and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cash Per Share

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Jack Nathan's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jack Nathan Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jack Nathan Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Jack Nathan's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 9.44 in 2025, whereas Sales General And Administrative To Revenue is likely to drop 0.61 in 2025.

	2022	2024	2025 (projected)
Gross Profit	11.8M	14.8M	9.7M
Interest Income	12.1K	10.9K	16.9K

Gross Profit Interest Income

Jack Nathan fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Other Assets	Capital Lease Obligations	Long Term Investments	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.98	0.47	0.4	0.71	0.11	-0.85	0.6	0.79	0.65	0.96	0.18	0.74	0.89	0.86	0.96	0.06	0.96	0.84	0.8	0.96	-0.77	0.71	-0.33	0.78	0.35
Other Current Liab	-0.98		-0.44	-0.43	-0.66	-0.15	0.8	-0.55	-0.87	-0.56	-0.91	-0.16	-0.71	-0.92	-0.9	-0.91	-0.15	-0.91	-0.77	-0.7	-0.91	0.73	-0.6	0.36	-0.7	-0.36
Total Current Liabilities	0.47	-0.44		-0.6	0.3	-0.77	-0.83	0.98	0.06	0.91	0.64	-0.72	0.94	0.11	0.15	0.65	-0.78	0.65	0.75	0.81	0.63	-0.92	0.8	-0.71	0.82	0.97
Total Stockholder Equity	0.4	-0.43	-0.6		0.44	0.92	0.12	-0.46	0.69	-0.34	0.16	0.93	-0.3	0.73	0.64	0.16	0.89	0.16	-0.07	-0.16	0.18	0.26	-0.24	0.29	-0.2	-0.67
Other Liab	0.71	-0.66	0.3	0.44		0.25	-0.5	0.43	0.58	0.54	0.62	0.38	0.49	0.74	0.65	0.61	0.14	0.62	0.49	0.51	0.62	-0.53	0.48	-0.6	0.47	0.15
Net Tangible Assets	0.11	-0.15	-0.77	0.92	0.25		0.42	-0.66	0.55	-0.6	-0.14	0.88	-0.55	0.5	0.5	-0.15	0.98	-0.15	-0.4	-0.47	-0.12	0.52	-0.54	0.39	-0.49	-0.77
Retained Earnings	-0.85	0.8	-0.83	0.12	-0.5	0.42		-0.9	-0.43	-0.91	-0.94	0.3	-0.96	-0.55	-0.53	-0.95	0.46	-0.94	-0.96	-0.96	-0.93	0.97	-0.92	0.48	-0.96	-0.73
Accounts Payable	0.6	-0.55	0.98	-0.46	0.43	-0.66	-0.9		0.18	0.96	0.75	-0.59	0.98	0.26	0.28	0.76	-0.7	0.76	0.82	0.88	0.74	-0.97	0.86	-0.7	0.89	0.92
Cash	0.79	-0.87	0.06	0.69	0.58	0.55	-0.43	0.18		0.14	0.62	0.4	0.35	0.94	0.98	0.61	0.57	0.61	0.37	0.28	0.63	-0.36	0.14	-0.21	0.28	0.04
Net Receivables	0.65	-0.56	0.91	-0.34	0.54	-0.6	-0.91	0.96	0.14		0.79	-0.41	0.94	0.31	0.27	0.8	-0.68	0.8	0.87	0.93	0.78	-0.95	0.94	-0.63	0.93	0.78
Common Stock Shares Outstanding	0.96	-0.91	0.64	0.16	0.62	-0.14	-0.94	0.75	0.62	0.79		-0.03	0.85	0.73	0.71	1.0	-0.19	1.0	0.95	0.92	1.0	-0.89	0.86	-0.35	0.92	0.53
Other Stockholder Equity	0.18	-0.16	-0.72	0.93	0.38	0.88	0.3	-0.59	0.4	-0.41	-0.03		-0.48	0.5	0.36	-0.04	0.8	-0.04	-0.21	-0.27	-0.02	0.43	-0.29	0.39	-0.32	-0.83
Total Liab	0.74	-0.71	0.94	-0.3	0.49	-0.55	-0.96	0.98	0.35	0.94	0.85	-0.48		0.42	0.44	0.86	-0.57	0.86	0.89	0.91	0.84	-0.99	0.88	-0.67	0.92	0.87
Net Invested Capital	0.89	-0.92	0.11	0.73	0.74	0.5	-0.55	0.26	0.94	0.31	0.73	0.5	0.42		0.95	0.72	0.47	0.72	0.51	0.44	0.73	-0.45	0.33	-0.24	0.42	0.01
Total Current Assets	0.86	-0.9	0.15	0.64	0.65	0.5	-0.53	0.28	0.98	0.27	0.71	0.36	0.44	0.95		0.7	0.48	0.71	0.46	0.4	0.72	-0.45	0.26	-0.23	0.4	0.11
Capital Stock	0.96	-0.91	0.65	0.16	0.61	-0.15	-0.95	0.76	0.61	0.8	1.0	-0.04	0.86	0.72	0.7		-0.2	1.0	0.95	0.93	1.0	-0.89	0.86	-0.35	0.92	0.53
Net Working Capital	0.06	-0.15	-0.78	0.89	0.14	0.98	0.46	-0.7	0.57	-0.68	-0.19	0.8	-0.57	0.47	0.48	-0.2		-0.2	-0.44	-0.53	-0.17	0.55	-0.62	0.38	-0.55	-0.74
Common Stock	0.96	-0.91	0.65	0.16	0.62	-0.15	-0.94	0.76	0.61	0.8	1.0	-0.04	0.86	0.72	0.71	1.0	-0.2		0.95	0.93	1.0	-0.89	0.86	-0.34	0.92	0.53
Property Plant Equipment	0.84	-0.77	0.75	-0.07	0.49	-0.4	-0.96	0.82	0.37	0.87	0.95	-0.21	0.89	0.51	0.46	0.95	-0.44	0.95		0.99	0.94	-0.92	0.96	-0.36	0.98	0.62
Property Plant And Equipment Net	0.8	-0.7	0.81	-0.16	0.51	-0.47	-0.96	0.88	0.28	0.93	0.92	-0.27	0.91	0.44	0.4	0.93	-0.53	0.93	0.99		0.92	-0.94	0.99	-0.41	1.0	0.67
Net Debt	0.96	-0.91	0.63	0.18	0.62	-0.12	-0.93	0.74	0.63	0.78	1.0	-0.02	0.84	0.73	0.72	1.0	-0.17	1.0	0.94	0.92		-0.88	0.85	-0.33	0.92	0.51
Other Assets	-0.77	0.73	-0.92	0.26	-0.53	0.52	0.97	-0.97	-0.36	-0.95	-0.89	0.43	-0.99	-0.45	-0.45	-0.89	0.55	-0.89	-0.92	-0.94	-0.88		-0.91	0.64	-0.95	-0.84
Capital Lease Obligations	0.71	-0.6	0.8	-0.24	0.48	-0.54	-0.92	0.86	0.14	0.94	0.86	-0.29	0.88	0.33	0.26	0.86	-0.62	0.86	0.96	0.99	0.85	-0.91		-0.4	0.98	0.65
Long Term Investments	-0.33	0.36	-0.71	0.29	-0.6	0.39	0.48	-0.7	-0.21	-0.63	-0.35	0.39	-0.67	-0.24	-0.23	-0.35	0.38	-0.34	-0.36	-0.41	-0.33	0.64	-0.4		-0.41	-0.69
Property Plant And Equipment Gross	0.78	-0.7	0.82	-0.2	0.47	-0.49	-0.96	0.89	0.28	0.93	0.92	-0.32	0.92	0.42	0.4	0.92	-0.55	0.92	0.98	1.0	0.92	-0.95	0.98	-0.41		0.71
Short Long Term Debt	0.35	-0.36	0.97	-0.67	0.15	-0.77	-0.73	0.92	0.04	0.78	0.53	-0.83	0.87	0.01	0.11	0.53	-0.74	0.53	0.62	0.67	0.51	-0.84	0.65	-0.69	0.71

Click cells to compare fundamentals

Jack Nathan Account Relationship Matchups

Jack Nathan fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	406.8K	10.7M	8.1M	6.5M	7.4M	5.7M
Total Current Liabilities	1.9M	960.1K	2.7M	5.6M	6.5M	6.8M
Total Stockholder Equity	389.6K	8.5M	4.1M	(1.9M)	(1.7M)	(1.6M)
Other Liab	579.2K	696.3K	710.8K	604.0K	694.6K	705.8K
Net Tangible Assets	(1.1M)	7.4M	892.4K	(3.2M)	(2.8M)	(2.7M)
Retained Earnings	(1.1M)	(11.0M)	(19.0M)	(25.9M)	(23.3M)	(22.2M)
Accounts Payable	458.1K	720.4K	1.8M	3.1M	3.6M	3.8M
Cash	406.8K	7.7M	1.1M	1.5M	1.7M	2.4M
Non Current Assets Total	1.6M	2.5M	5.9M	3.9M	4.5M	3.1M
Net Receivables	63.9K	156.6K	831.9K	826.9K	951.0K	998.5K
Non Current Liabilities Total	902.2K	1.2M	1.4M	2.7M	3.1M	3.3M
Other Stockholder Equity	(24.8K)	150.0K	141.5K	(107.2K)	(96.4K)	(91.6K)
Total Liab	17.2K	2.1M	4.1M	8.3M	9.6M	10.0M
Net Invested Capital	389.6K	8.9M	4.4M	1.9M	2.2M	3.5M
Total Current Assets	107.8K	8.1M	2.2M	2.5M	2.9M	3.0M
Capital Stock	513.3K	18.5M	19.6M	19.8M	22.7M	12.9M
Net Working Capital	389.6K	7.2M	(455.9K)	(3.1M)	(2.8M)	(2.6M)
Property Plant Equipment	869.8K	1.2M	2.6M	2.6M	2.9M	1.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Jack Stock Analysis

When running Jack Nathan's price analysis, check to measure Jack Nathan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jack Nathan is operating at the current time. Most of Jack Nathan's value examination focuses on studying past and present price action to predict the probability of Jack Nathan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jack Nathan's price. Additionally, you may evaluate how the addition of Jack Nathan to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC